Alzheimer's disease studies
Alzheimer's disease clinical trials, on your terms
Clinical Trials for Alzheimer's Disease shows you which studies are recruiting and puts you in touch with a study team. The studies themselves look into investigational medications, diagnostic tools, and care approaches for people with memory and thinking changes, and for those who care for them. You begin with a short conversation. It costs nothing and commits you to nothing.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed

Alzheimer's disease studies in numbers
- Alzheimer's disease studies recruiting in the U.S.
- 288
- states with a study site
- 43
- cities with a study site
- 308
- studies that accept healthy volunteers
- 134
Source: ClinicalTrials.gov. Data processed .
Find Alzheimer's disease studies near you
These states have the most studies recruiting right now.
California
62 studies recruiting.
Florida
61 studies recruiting.
Massachusetts
48 studies recruiting.
Texas
47 studies recruiting.
New York
44 studies recruiting.
All locations
Browse every state and city with a recruiting study.
Alzheimer's disease studies recruiting now
As of November 16, 2026, 288 Alzheimer's disease studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.
What they test
- medications101
- behavioral approaches such as talk therapy or training73
- other approaches55
- devices43
- diagnostic tests11
A study can test more than one.
Main purpose
- treating a condition116
- prevention25
- diagnosis24
- supportive care24
Phase
- Early Phase 14
- Phase 122
- Phase 1/214
- Phase 245
- Phase 2/34
- Phase 319
- Phase 45
- No phase115
- Observational60
Studies of devices and behavioral approaches have no phase.
Who runs them
- university, hospital or other209
- industry70
- government9
Who they enroll
- adults (18 to 64)264
- older adults (65 and over)281
- children (under 18)5
134 also accept healthy volunteers.
Where: sites in 43 states. The cities with the most are Boston, MA (27), St Louis, MO (25), Miami, FL (24), New York, NY (22), Tampa, FL (20), Maitland, FL (19), Orlando, FL (19), Indianapolis, IN (17).
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 288 studies.
Recently updated Alzheimer's disease studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
- Observational
- Ages 30 to 90
- All sexes
- Sponsor
- VA Office of Research and Development
- Recruiting in
- Boston, MA
- Registry record
- NCT04124029 · updated
PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)
- Observational
- Ages 55 to 110
- All sexes
- Sponsor
- National Institute on Aging (NIA)
- Recruiting in
- Baltimore, MD
- Registry record
- NCT07099053 · updated
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
- Phase 1
- Ages 50 to 100
- All sexes
- Sponsor
- National Institute of Mental Health (NIMH)
- Recruiting in
- Bethesda, MD
- Registry record
- NCT07169630 · updated
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Arlington, VA · Atlanta, GA · Atlantis, FL · and 52 more U.S. locations
- Registry record
- NCT07177352 · updated
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
- Phase 2
- Ages 65 to 120
- All sexes
- Sponsor
- National Institute on Aging (NIA)
- Recruiting in
- Baltimore, MD
- Registry record
- NCT07721467 · updated
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
- Phase 2
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Laurelton, NY · Stuart, FL · Wellington, FL · and 1 more U.S. location
- Registry record
- NCT07781657 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in the United States on ClinicalTrials.gov.
Not sure which study fits?
Tell a coordinator what you are looking for. They will explain which Alzheimer's disease studies may be worth a closer look and what the next step is. Asking does not commit you to anything.
What Alzheimer's disease studies look at
An Alzheimer's disease study might look at an investigational medication, a diagnostic tool, or an approach to care. These studies involve people with memory and thinking changes, and also the people who care for them. Because each one is built around a single specific question, what you or your family member would be asked to do changes from one study to the next.
Whatever a study is testing is investigational. Researchers are still finding out how well it works and what risks it carries. That is why the study is being run in the first place.
Who may be able to take part
There is no single answer, because each Alzheimer's disease study writes its own rules. A study team might look at how old you are, your medical background, the medicines you take now, and what the condition is like for you day to day. People without the condition are enrolled in some studies too.
Working out whether you or your family member fits is not your job. The study team checks that at a screening visit. Here is how eligibility and screening work.
How taking part works
There are four steps. At each one, you decide whether to go on.
Tell us what you are looking for
Tell us which condition or type of study interests you, either by calling or by sending a short form.
Talk with a coordinator
You talk with a coordinator, who walks you through the Alzheimer's disease studies that could fit and gives clear, everyday answers to whatever you or your family want to ask.
Meet the study team
Should you choose to go further, the study team takes you through the study in detail and checks your eligibility.
Decide what is right for you
The decision stays with you. Joining is voluntary, and whatever your reason, you are free to withdraw from a study whenever you choose.
Why people take part in Alzheimer's disease studies
The reasons vary from person to person, and each one is worth a conversation before you or your family decide anything.
- Some want a research team keeping a close eye on their health while the study runs.
- Some hope to understand more about a condition they are living with.
- Some like the idea of contributing to research whose answers could influence how others are cared for down the road.
Research and treatment are not the same thing. A clinical trial is research, and a personal benefit from joining is something no one is able to promise you. If you would like it explained simply, read what a clinical trial is.
Your safety and your rights come first
Before any study can enroll a single person, an independent ethics committee has to review it. You also get the details in writing before agreeing to anything. You can read how informed consent works, how studies are reviewed and monitored, and which rights you keep the whole way through.
Common questions about Alzheimer's disease studies
Do I need a diagnosis to join a study about Alzheimer's disease?
That changes from study to study. Certain studies only take people whose diagnosis has already been confirmed, and in others the assessment happens as part of screening. The team running the study will tell you which of the two holds for theirs.
Would I have to change the care I receive now?
Please do not change any care on your own. Current care can continue in some studies and not in others. The study doctor goes over this with you, and before you decide you can also talk it through with your own doctor.
Is there a cost to take part?
As a rule, the visits, tests, and medication that are part of a study come at no cost to the people taking part. Our page on costs goes into more detail.
Does it cost anything to ask about a study?
No. You pay nothing to talk with Clinical Trials for Alzheimer's Disease, and you are not signed up for anything by asking questions.
Do I have to take part if I call?
No. Whether to continue is your call at every step, and you can stop whenever you choose.
Who decides whether I can join a study?
The study team makes that call once you have been to a screening visit. Every study works from its own list of criteria. Find out what happens at screening.
Ask about Alzheimer's disease studies
Tell us a little about yourself or the person you are helping, then expect to hear back from a coordinator. A question is just a question, and it creates no obligation.
Learn more from independent sources
- What Is Alzheimer's Disease? — National Institute on Aging (NIH)
- Clinical Trials — MedlinePlus (National Library of Medicine)
- About Research Participation — HHS Office for Human Research Protections
- Learn About Studies — ClinicalTrials.gov (National Library of Medicine)